Outlook on the NIPT Global Market to 2030 - Availability of Direct to Consumer Tests Presents Opportunities - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global NIPT Market: Focus on Test Type, Platform, Method, Application, End-User, 5 Regional Data, 25 Countries' Data, Competitive Landscape, Regulatory and Reimbursement Scenario - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. Currently, NIPT is considered a valuable test for pregnant women to provide cost-effective and highly efficient early diagnosis of genetic disorders. Moreover, advancements in genome sequencing technologies reduce turnaround time and the complexity of diagnosis with next-generation sequencing (NGS). The NGS technology provides several opportunities to develop non-invasive diagnostic procedures for early and accurate detection of various genetic disorders.
The life science industry is witnessing significant growth of NIPT tests developed using the NGS technology. Several biotechnology companies are now indulging in the research and development of such NGS-based NIPT products. Furthermore, the advent of genome sequencing technologies in the life science industry has enabled the companies to detect genetic diseases at an early stage and provide accurate results to remain competitive in the market.
Our healthcare experts have found global NIPT market as one of the most rapidly evolving markets amongst the other prenatal testing industries. The purpose of this study is to gain a holistic view of the NIPT market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the tests associated with the global NIPT market across different regions. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.
This research report aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.
Key Questions Answered Include:
- What is the importance of NIPT, and what are the different NIPT products/services available in the market? What are the different methods of NIPT, and what are the benefits and risks associated with it?
- What are the major technological advancements witnessed by the global NIPT market in the past four years, and what is the future scope of the market? What are the key trends of the global NIPT market as per the year 2020, and how is the market evolving currently?
- What were the market size and market volume of the global NIPT market in 2019, and what are the market size and market volume anticipated to be in 2030? What is the expected growth rate of the global NIPT market during the period between 2020 and 2030?
- What is the market scenario and growth potential of different regions of the world, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
- What are the major drivers, challenges, and opportunities of the global NIPT market?
- What are the major key players of the global NIPT market? How much market share does each of these players occupy in the market in 2019? Which companies are anticipated to be highly disruptive in the future, and why?
- What is the regulatory scenario of the global NIPT market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of NIPT products?
Market Dynamics
Drivers
- Increased Emphasis on Early Detection and Prevention
- Availability of Advanced Screening Technologies
- Increasing Consumer Demand
- Shifting of Reimbursement Policies Toward More Genetics Coverage
- High Incidence Rate of Down's Syndrome
- Rising Average Maternal Age
- Increasing Prevalence of Genetic and Congenital Disorders
Restraints
- Stringent Regulatory Guidelines and Ethical Hurdles
- Limitations of NIPT
- Lack of Awareness Among Consumers
- Alternative Screening and Testing Methods
Opportunities
- Capitalizing on the Potential Presented by the Emerging Markets of Asia
- Availability of Direct to Consumer Tests
- Focus on Pre-Implantation Genetic Diagnosis
Companies Mentioned
- Agilent Technologies, Inc.
- Annoroad Gene Technology
- BGI
- CENTOGENE N.V.
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- MedGenome Inc.
- Myriad Genetics, Inc.
- Natera, Inc.
- Next Biosciences
- PerkinElmer, Inc.
- Quest Diagnostics Incorporated
- Yourgene Health PLC
For more information about this report visit https://www.researchandmarkets.com/r/6eg0pv
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
